Alexion could be target for buyout
Biotechnology colossus Amgen could be nearing a deal to acquire Alexion Pharmaceuticals, the highly specialized orphan drug manufacturer that received and then paid back millions i…
Biotechnology colossus Amgen could be nearing a deal to acquire Alexion Pharmaceuticals, the highly specialized orphan drug manufacturer that received and then paid back millions i…